annual EBITDA:
$109.91M+$201.22M(+220.36%)Summary
- As of today (September 11, 2025), KRYS annual EBITDA is $109.91 million, with the most recent change of +$201.22 million (+220.36%) on December 31, 2024.
- During the last 3 years, KRYS annual EBITDA has risen by +$176.14 million (+265.95%).
- KRYS annual EBITDA is now at all-time high.
Performance
KRYS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$40.85M+$3.04M(+8.04%)Summary
- As of today (September 11, 2025), KRYS quarterly EBITDA is $40.85 million, with the most recent change of +$3.04 million (+8.04%) on June 30, 2025.
- Over the past year, KRYS quarterly EBITDA has increased by +$17.80 million (+77.21%).
- KRYS quarterly EBITDA is now -4.93% below its all-time high of $42.97 million, reached on December 31, 2024.
Performance
KRYS quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$158.05M+$17.80M(+12.69%)Summary
- As of today (September 11, 2025), KRYS TTM EBITDA is $158.05 million, with the most recent change of +$17.80 million (+12.69%) on June 30, 2025.
- Over the past year, KRYS TTM EBITDA has increased by +$147.72 million (+1430.15%).
- KRYS TTM EBITDA is now at all-time high.
Performance
KRYS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
KRYS EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +220.4% | +77.2% | +1430.2% |
3 y3 years | +265.9% | +247.1% | +279.7% |
5 y5 years | +623.6% | +722.7% | +784.0% |
KRYS EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +194.1% | -4.9% | +210.9% | at high | +216.0% |
5 y | 5-year | at high | +194.1% | -4.9% | +210.9% | at high | +216.0% |
alltime | all time | at high | +194.1% | -4.9% | +210.9% | at high | +216.0% |
KRYS EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $40.85M(+8.0%) | $158.05M(+12.7%) |
Mar 2025 | - | $37.81M(-12.0%) | $140.25M(+27.7%) |
Dec 2024 | $109.91M(-220.4%) | $42.97M(+18.0%) | $109.86M(+53.6%) |
Sep 2024 | - | $36.42M(+58.0%) | $71.54M(+592.6%) |
Jun 2024 | - | $23.05M(+210.5%) | $10.33M(-120.8%) |
Mar 2024 | - | $7.42M(+59.8%) | -$49.57M(-46.2%) |
Dec 2023 | -$91.32M(-21.8%) | $4.64M(-118.7%) | -$92.22M(-29.4%) |
Sep 2023 | - | -$24.79M(-32.7%) | -$130.55M(-4.2%) |
Jun 2023 | - | -$36.85M(+4.6%) | -$136.23M(+7.1%) |
Mar 2023 | - | -$35.22M(+4.6%) | -$127.16M(+9.5%) |
Dec 2022 | -$116.81M(+76.4%) | -$33.68M(+10.5%) | -$116.14M(+12.2%) |
Sep 2022 | - | -$30.48M(+9.7%) | -$103.55M(+17.7%) |
Jun 2022 | - | -$27.78M(+14.7%) | -$87.94M(+15.9%) |
Mar 2022 | - | -$24.21M(+14.8%) | -$75.90M(+15.9%) |
Dec 2021 | -$66.23M(+118.5%) | -$21.09M(+41.9%) | -$65.51M(+20.5%) |
Sep 2021 | - | -$14.87M(-5.5%) | -$54.34M(+11.5%) |
Jun 2021 | - | -$15.73M(+13.8%) | -$48.76M(+23.2%) |
Mar 2021 | - | -$13.82M(+39.1%) | -$39.59M(+26.3%) |
Dec 2020 | -$30.32M | -$9.93M(+7.0%) | -$31.36M(+14.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2020 | - | -$9.28M(+41.5%) | -$27.30M(+18.2%) |
Jun 2020 | - | -$6.56M(+17.5%) | -$23.11M(+4.1%) |
Mar 2020 | - | -$5.58M(-5.0%) | -$22.20M(+5.2%) |
Dec 2019 | -$20.99M(+78.3%) | -$5.88M(+15.6%) | -$21.11M(+8.9%) |
Sep 2019 | - | -$5.08M(-10.0%) | -$19.39M(+12.5%) |
Jun 2019 | - | -$5.65M(+25.7%) | -$17.24M(+23.0%) |
Mar 2019 | - | -$4.50M(+8.1%) | -$14.01M(+19.0%) |
Dec 2018 | -$11.78M(+147.9%) | -$4.16M(+41.7%) | -$11.78M(+29.4%) |
Sep 2018 | - | -$2.93M(+20.9%) | -$9.10M(+10.2%) |
Jun 2018 | - | -$2.43M(+7.4%) | -$8.26M(+26.2%) |
Mar 2018 | - | -$2.26M(+52.2%) | -$6.54M(+37.8%) |
Dec 2017 | -$4.75M(+316.2%) | -$1.48M(-28.9%) | -$4.75M(+22.3%) |
Sep 2017 | - | -$2.09M(+193.3%) | -$3.88M(+83.4%) |
Jun 2017 | - | -$712.00K(+53.4%) | -$2.12M(+31.9%) |
Mar 2017 | - | -$464.00K(-25.0%) | -$1.60M(+40.7%) |
Dec 2016 | -$1.14M | -$619.00K(+92.2%) | -$1.14M(+118.6%) |
Sep 2016 | - | -$322.00K(+61.0%) | -$522.00K(+161.0%) |
Jun 2016 | - | -$200.00K(<-9900.0%) | -$200.00K(<-9900.0%) |
Mar 2016 | - | $0.00 | $0.00 |
FAQ
- What is Krystal Biotech, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Krystal Biotech, Inc.?
- What is Krystal Biotech, Inc. annual EBITDA year-on-year change?
- What is Krystal Biotech, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Krystal Biotech, Inc.?
- What is Krystal Biotech, Inc. quarterly EBITDA year-on-year change?
- What is Krystal Biotech, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Krystal Biotech, Inc.?
- What is Krystal Biotech, Inc. TTM EBITDA year-on-year change?
What is Krystal Biotech, Inc. annual EBITDA?
The current annual EBITDA of KRYS is $109.91M
What is the all time high annual EBITDA for Krystal Biotech, Inc.?
Krystal Biotech, Inc. all-time high annual EBITDA is $109.91M
What is Krystal Biotech, Inc. annual EBITDA year-on-year change?
Over the past year, KRYS annual EBITDA has changed by +$201.22M (+220.36%)
What is Krystal Biotech, Inc. quarterly EBITDA?
The current quarterly EBITDA of KRYS is $40.85M
What is the all time high quarterly EBITDA for Krystal Biotech, Inc.?
Krystal Biotech, Inc. all-time high quarterly EBITDA is $42.97M
What is Krystal Biotech, Inc. quarterly EBITDA year-on-year change?
Over the past year, KRYS quarterly EBITDA has changed by +$17.80M (+77.21%)
What is Krystal Biotech, Inc. TTM EBITDA?
The current TTM EBITDA of KRYS is $158.05M
What is the all time high TTM EBITDA for Krystal Biotech, Inc.?
Krystal Biotech, Inc. all-time high TTM EBITDA is $158.05M
What is Krystal Biotech, Inc. TTM EBITDA year-on-year change?
Over the past year, KRYS TTM EBITDA has changed by +$147.72M (+1430.15%)